It is the belief of Carbiotix that activity within the gut microbiome is more important than the presence
of specific bacteria species. As such, the company is focused on engineering microbiome modulators (proprietary
second-generation soluble fibers, isolated bacterial strains and novel delivery mechanisms) to
restore and optimize gut microbiome metabolic processes and thereby obtain a desired therapeutic effect
through an improved metabolic profile.
The microbiome modulators are designed to promote carbohydrate fermentation and the production of Short Chain
Fatty Acids (SCFAs) or healthy metabolites, and limit protein fermentation and the production of harmful metabolites
such NH3, amines and phenolics. The SCFAs provide energy for colonocytes, intestinal motility, nutrient absorption,
colonic pH maintenance, immune enhancement and have an antineoplastic property.